Rezultati pretraživanja
  1. prije 2 sata

    Check out my colleague ’s new cost-effectiveness analysis of restrict housing vouchers to help guide housing policy!

  2. prije 7 sati

    Are you highly skilled in quantitative sciences and experienced with programming languages? Take a look at this position working with our modeling team.

  3. prije 8 sati

    This open access🔓systematic literature review from authors identified 37 unique research issues that were raised as challenges to integrating patient preferences in health technology assessment.

  4. Clinerion and Datametrix announced a new partnership in which the organizations will generate insights using from Clinerion’s hospital network. |

  5. "Drug Quality: FDA officials discuss perceptions" via

  6. New at CADTH: updated review process, economic methods, and submission requirements >>

  7. prije 13 sati
  8. "Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix" via

  9. The Medical Affairs Professional Society announced its lineup of keynote speakers for its upcoming meeting set to kick off March 8 in Miami, Florida. |

  10. 5. velj

    A new FirstWord report shifts the spotlight to pricing and reimbursement for innovative drugs in major non-U.S. markets. |

  11. 4. velj

    A slate of Democratic legislators have invited affordability activists as their guests to tonight’s State of the Union address, STAT reports. More details inside. |

  12. 4. velj

    A recent article published in the Journal of Medical Economics looks at the progress of Japan’s program, which was institutionalized in April last year. |

  13. 4. velj

    "The 10 most-anticipated drug launches of 2020" via

  14. 4. velj

    High-cost combinations >> Will the scale of high-cost combinations coming to market force a significant change in pricing and reimbursement policies?

  15. 4. velj

    Please check out a recent paper from in Statistics in Medicine which introduces a stochastic differential equation method for modeling cohort process in decision modeling and cost-effectiveness analysis . In sum:

    Prikaži ovu nit
  16. 4. velj

    Copyright Clearance Center and are joining forces to offer integrated document delivery through CCC’s cloud-based RightFind solution within Evidence Partners’ DistillerSR platform. More details inside! |

  17. 3. velj

    Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year, according to a Pink Sheet report. |

  18. 3. velj

    Why join us? We pride ourselves on a culture of family and opportunity. Learn more.

  19. 3. velj

    We've added 17,800 abstracts on to our database in 2019

  20. 2. velj

    Go and check "I'm never stop" is very emotional and amazing!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.